MedPath

YUNNAN BAIYAO GROUP CO.,LTD.

Ownership
-
Established
1993-11-30
Employees
3.9K
Market Cap
-
Website
www.yunnanbaiyao.com.cn
Introduction

The company was founded in 1902, integrates brands, products and company names, and is recognized by the industry as the most innovative representative of time-honored Chinese brands. As an old Chinese national brand with a history of 122 years, Yunnan Baiyao has always been committed to promoting the integration of traditional traditional Chinese medicine into modern life, continuously exploring the endogenous potential of traditional medicine products, responding to the needs of modern life with product innovation, and continuously injecting new vitality into traditional brands and traditional Chinese medicine products. The company uses the four major business groups of pharmaceuticals, health products, traditional Chinese medicine resources, and Yunnan Pharmaceutical Company as the core base of production and operation. The company's main products include Yunnan Baiyao aerosol, Yunnan Baiyao ointment, Yunnan Baiyao band-aids, etc. Company honors: “2017 China's Top 500 Corporate Social Responsibility” list, Yunnan Baiyao ranked 55th; on March 26, BrandZ released the 2018 Top 100 Most Valuable Chinese Brands, Yunnan Baiyao ranked 28th, ranking first in the medical and health care sector for 7 consecutive years. On April 8, Yunnan Baiyao ranked 5th in the “2017 Top 100 Listed Companies Most Respected by Investors” list of the China Association of Listed Companies, etc.

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

397

NMPA:397

Drug Approvals

Tongshu Tablets

Product Name
痛舒片
Approval Number
国药准字Z20090515
Approval Date
Mar 5, 2024
NMPA

Fibrauretine Suppositories

Product Name
黄藤素栓
Approval Number
国药准字H20083627
Approval Date
Apr 21, 2023
NMPA

银杏叶片

Approval Number
国药准字Z20073128
Approval Date
Mar 3, 2022
NMPA

健胃消食片

Approval Number
国药准字Z20073129
Approval Date
Mar 3, 2022
NMPA

养之素<sup>®</sup>三七人参口服液

Approval Number
国食健注G20050533
Approval Date
Jan 25, 2022
NMPA

莲芝消炎片

Approval Number
国药准字Z20064338
Approval Date
Jul 28, 2021
NMPA

板蓝根颗粒

Approval Number
国药准字Z20044076
Approval Date
Apr 30, 2021
NMPA

香砂平胃颗粒

Approval Number
国药准字Z53021561
Approval Date
Jun 25, 2020
NMPA

熟三七散

Approval Number
国药准字Z20026861
Approval Date
Jun 22, 2020
NMPA

复方丹参胶囊

Approval Number
国药准字Z20026467
Approval Date
Jun 22, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 40
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.